Cardiovascular news

'Game-changing' new cholesterol-lowering drug to be given by GPs

'Game-changing' new cholesterol-lowering drug to be given by GPs

Draft guidance from NICE recommends inclisiran (Leqvio)...

Irbesartan batches recalled over contamination

Irbesartan batches recalled over contamination

Batches of some irbesartan-containing products are...

Second SGLT2 inhibitor approved for heart failure

Second SGLT2 inhibitor approved for heart failure

Clinicians now have a choice of SGLT2 inhibitors to...

New research supports statin prescribing in patients over 75 years

New research supports statin prescribing in patients over 75 years

Evidence suggesting a mortality benefit of statins...

Prescribe antihypertensives to reduce cardiovascular risk regardless of blood pressure, say researchers

Prescribe antihypertensives to reduce cardiovascular risk regardless of blood pressure, say researchers

Prescribers should consider blood pressure-lowering...

Updated NICE atrial fibrillation guidance recommends newer anticoagulants

Updated NICE atrial fibrillation guidance recommends newer anticoagulants

Direct-acting oral coagulants should be offered to...

New oral lipid-lowering treatment approved by NICE

New oral lipid-lowering treatment approved by NICE

Bempedoic acid (Nilemdo) has been approved for routine...

'Innovative' heart failure treatment recommended by NICE

'Innovative' heart failure treatment recommended by NICE

Dapagliflozin (Forxiga), the first SGLT2 inhibitor...

New lipid-lowering treatment available to prescribe

New lipid-lowering treatment available to prescribe

Bempedoic acid (Nilemdo) is a new oral treatment option...

Most statin side-effects down to 'nocebo' effect, study suggests

Most statin side-effects down to 'nocebo' effect, study suggests

90% of the symptom burden reported with statins was...

Diabetes drug approved to treat heart failure

Diabetes drug approved to treat heart failure

Forxiga (dapagliflozin) is the first SGLT2 inhibitor...

MHRA urges GPs to ensure continued INR monitoring during pandemic

MHRA urges GPs to ensure continued INR monitoring during pandemic

The MHRA advice was issued following reports of an...

New MIMS table to guide antihypertensive monitoring in primary care

New MIMS table to guide antihypertensive monitoring in primary care

Monitoring requirements for ACE inhibitors and angiotensin...

Statin prescribing 'commonly breaching NICE guidance'

Statin prescribing 'commonly breaching NICE guidance'

Prescribing of suboptimal statin regimens is 'extremely...

Stopping antihypertensives in elderly may be safe

Stopping antihypertensives in elderly may be safe

Discontinuing antihypertensive medication in older...

Quadruple therapy should be 'new therapeutic standard' for heart failure, say researchers

Quadruple therapy should be 'new therapeutic standard' for heart failure, say researchers

Treatment with a four-drug regimen incorporating newer...

'No convincing alternative' to aspirin for secondary cardiovascular prevention, meta-analysis suggests

'No convincing alternative' to aspirin for secondary cardiovascular prevention, meta-analysis suggests

In a meta-analysis of randomised trials, patients who...

GPs overestimate benefits and harms of treatments, say researchers

GPs overestimate benefits and harms of treatments, say researchers

GPs’ knowledge of the absolute benefits and harms of...

Omega-3 supplements withdrawn from secondary prevention use

Omega-3 supplements withdrawn from secondary prevention use

Omega-3 fatty acids can no longer be prescribed to...

Thiazides better than ACE inhibitors as first-line antihypertensives, large-scale analysis suggests

Thiazides better than ACE inhibitors as first-line antihypertensives, large-scale analysis suggests

Thiazide diuretics are more effective than ACE inhibitors...